(4-(6-chlorobenzo[d]thiazol-2-yl)-1,4-diazepan-1-yl)(2,6-dimethoxyphenyl)methanone

ID: ALA3586412

Chembl Id: CHEMBL3586412

PubChem CID: 2796191

Max Phase: Preclinical

Molecular Formula: C21H22ClN3O3S

Molecular Weight: 431.95

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cccc(OC)c1C(=O)N1CCCN(c2nc3ccc(Cl)cc3s2)CC1

Standard InChI:  InChI=1S/C21H22ClN3O3S/c1-27-16-5-3-6-17(28-2)19(16)20(26)24-9-4-10-25(12-11-24)21-23-15-8-7-14(22)13-18(15)29-21/h3,5-8,13H,4,9-12H2,1-2H3

Standard InChI Key:  IWNLDQPKTBRWAF-UHFFFAOYSA-N

Associated Targets(Human)

HCRTR2 Tclin Orexin receptor 2 (5902 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCRTR1 Tclin Orexin receptor 1 (5435 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 431.95Molecular Weight (Monoisotopic): 431.1070AlogP: 4.32#Rotatable Bonds: 4
Polar Surface Area: 54.90Molecular Species: NEUTRALHBA: 6HBD: 0
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 2.48CX LogP: 4.18CX LogD: 4.18
Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.62Np Likeness Score: -2.03

References

1. Letavic MA, Bonaventure P, Carruthers NI, Dugovic C, Koudriakova T, Lord B, Lovenberg TW, Ly KS, Mani NS, Nepomuceno D, Pippel DJ, Rizzolio M, Shelton JE, Shah CR, Shireman BT, Young LK, Yun S..  (2015)  Novel Octahydropyrrolo[3,4-c]pyrroles Are Selective Orexin-2 Antagonists: SAR Leading to a Clinical Candidate.,  58  (14): [PMID:26087021] [10.1021/acs.jmedchem.5b00742]
2. Roecker AJ, Cox CD, Coleman PJ..  (2016)  Orexin Receptor Antagonists: New Therapeutic Agents for the Treatment of Insomnia.,  59  (2): [PMID:26317591] [10.1021/acs.jmedchem.5b00832]
3. Sun S, Fu J..  (2018)  Methyl-containing pharmaceuticals: Methylation in drug design.,  28  (20.0): [PMID:30243589] [10.1016/j.bmcl.2018.09.016]

Source